Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice

The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole. Against infections induced by strains with various susceptibilities to fluconazole, the efficacy of fluc...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kamai, Yasuki, Kubota, Mikie, Fukuoka, Takashi, Kamai, Yoko, Maeda, Naoyuki, Hosokawa, Tsunemichi, Shibayama, Takahiro, Uchida, Katsuhisa, Yamaguchi, Hideyo, Kuwahara, Shogo
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2003
Témata:
Experimental Therapeutics
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC151753/
https://ncbi.nlm.nih.gov/pubmed/12543666
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.2.601-606.2003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky